A Comparison of Fosaprepitant and Ondansetron for Preventing Postoperative Nausea and Vomiting in Moderate to High Risk Patients: A Retrospective Database Analysis

Table 3

Nausea and NRS.

	NK1 group,	ONS group,
0–2 hours
Severity of nausea (0/1/2/3)	48/15/10/9	65/6/4/14
2–24 hours
Severity of nausea (0/1/2/3)	62/10/6/4	57/10/10/12
24–48 hours
Severity of nausea (0/1/2/3)	76/5/1/0	77/6/2/4

Data are presented as number of patients or median (interquartile range); NK1 group, i.v. fosaprepitant; ONS group, i.v. ondansetron; severity of nausea: 0 = absence of nausea, 1 = mild nausea, 2 = moderate nausea, and 3 = severe nausea.